Protalix Biotherapeutics Inc (PLX)
US$ 1.46-15.12%
Price Chart
Key Statistics
Market Cap
$ 113.84M
P/E Ratio
27.40
Revenue (TTM)
$ 59.76M
Volume
5.56M
52W High
$ 3.10
52W Low
$ 0.82
Dividend Yield
0.00%
Beta
-0.22
Technicals
50-Day MA
2.1032
200-Day MA
1.8608
52 Week High
3.1
52 Week Low
0.8214
About PLX
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based p.
Employees
213
Headquarters
Hackensack, NJ
CEO
Mr. Dror Bashan
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg